• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Namestent, urethral, prostatic, permanent or semi-permanent
Generic Namestent, urethral, prostatic, permanent or semi-permanent
Boston Scientific Corp.
100 boston scientific way
marlborough, MA 01752
PMA NumberP920023
Supplement NumberS001
Date Received05/06/1996
Decision Date04/11/1997
Product Code
Docket Number 98M-0050
Notice Date 02/09/1998
Advisory Committee Gastroenterology/Urology
Supplement Typepanel track
Supplement Reason labeling change - indications/instructions/shelf life/tradename
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the urolume(tm) endourethral prosthesis for prostatic obstruction secondary to benign prostatic hypertrophy(bph). This device is intended to relieve prostatic obstruction secondary to bph in men at least 60 yrs of age, or men under 60 years of age who are poor surgical candidates, and whose prostates are at least 2. 5cm in length.